Detalhe da pesquisa
1.
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Blood
; 141(14): 1685-1690, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608320
2.
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Blood
; 142(19): 1633-1646, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390336
3.
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.
Br J Haematol
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719214
4.
Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356448
5.
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma.
Haematologica
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572568
6.
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain.
Eur J Haematol
; 112(5): 701-713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146208
7.
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
Cancer
; 129(23): 3746-3760, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622738
8.
Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
Blood
; 138(18): 1721-1726, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115836
9.
BCMA loss in the epoch of novel immunotherapy for multiple myeloma: from biology to clinical practice.
Haematologica
; 108(4): 958-968, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263838
10.
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the ß2 and ß1 subunits of the proteasome complex.
Haematologica
; 108(6): 1628-1639, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727403
11.
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells.
Haematologica
; 108(2): 568-580, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722406
12.
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma.
Br J Haematol
; 198(3): 515-522, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582835
13.
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lancet Oncol
; 21(2): 207-221, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859245
14.
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
Oncologist
; 25(2): 112-118, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043788
15.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
16.
Venetoclax salvage therapy in relapsed/refractory multiple myeloma.
Haematologica
; 109(3): 979-981, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794827
17.
Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.
Eur J Nucl Med Mol Imaging
; 46(7): 1407-1416, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798427
18.
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma.
Int J Mol Sci
; 20(5)2019 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871078
19.
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
Blood
; 128(9): 1226-33, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458004
20.
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.
Haematologica
; 103(11): 1772-1784, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171031